Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461421 · ClinicalTrials.gov registry record · NA
Acceptance Based Behavioral Intervention for Weight Loss: A Randomized Trial
A NA study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT01461421: Completed NA study, sponsored by The Miriam Hospital.
NCT01461421 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461421, a NA study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The proposed project is testing two behavioral interventions designed to improve long-term weight loss among participants who struggle with eating in response to stress or emotional experiences. Group treatment lasts for 1 year, with assessments lasting 2 years. Participants must live in the greater Providence, Rhode Island area in order to be eligible.
Primary Outcome
Amount of weight lost (kg) from initial body weight at study entry.
Interventions
- BEHAVIORAL Nutrition Education
- BEHAVIORAL Behavioral Weight Loss Strategies
- BEHAVIORAL Standard Cognitive Techniques
- BEHAVIORAL Acceptance Based Techniques
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-03 |
| Phase | NA |
What the finished NCT01461421 record still lists
NCT01461421 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 4 interventions - of which Nutrition Education is the first listed.
NCT01461421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461421 about?
NCT01461421 is a clinical study titled "Acceptance Based Behavioral Intervention for Weight Loss: A Randomized Trial". The proposed project is testing two behavioral interventions designed to improve long-term weight loss among participants who struggle with eating in response to stress or emotional experiences. Group treatment lasts for 1 year, with assessments lasting 2 years. Participants must live in the greater...
What is the current status of trial NCT01461421?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2011-07. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01461421?
The interventions under investigation include: Nutrition Education (BEHAVIORAL), Behavioral Weight Loss Strategies (BEHAVIORAL), Standard Cognitive Techniques (BEHAVIORAL), Acceptance Based Techniques (BEHAVIORAL).
Who is sponsoring clinical trial NCT01461421?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01461421's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia